Following a phase 3 knee…
Following a phase 3 knee osteoarthritis failure that its CEO [...]
BioMarin Pharmaceutical has agreed…
BioMarin Pharmaceutical has agreed to buy Alesta Therapeutics for $275 [...]
Amylyx Pharmaceuticals’ $35…
Amylyx Pharmaceuticals’ $35 million bet on the GLP-1 receptor antagonist [...]
Regeneron has hit the brakes on…
Regeneron has hit the brakes on the phase 1/2a trial [...]
Slate Medicines is hurtling toward…
Slate Medicines is hurtling toward a Nasdaq listing, securing a [...]
Evaxion has scrapped a next-gen…
Evaxion has scrapped a next-gen solid tumor vaccine in order [...]
Antibody platform business OmniAb…
Antibody platform business OmniAb continues to rack up the Big [...]
Skye Bioscience has entered into…
Skye Bioscience has entered into an agreement to combine with [...]
BioCryst CEO Charlie Gayer told…
BioCryst CEO Charlie Gayer told Fierce the company is “not [...]
Capricor Therapeutics has bounced…
Capricor Therapeutics has bounced back from a bruising FDA advisory [...]